Here’s the Deal: Karo Healthcare

Important Information

This website and the materials herein are only intended and directed to Institutional, Professional or Accredited Investors, as defined in your jurisdiction.

Before accessing this website, please select one of the following option:

I confirm I am resident in one of the countries below (drop down menu) and I am a professional investor as defined in my jurisdiction.

Please select a jurisdiction.

Products or services that may be mentioned are subject to legal and regulatory requirements and may not be available in all jurisdictions. Accordingly, you are required to inform yourself and observe any such restrictions.

By visiting this website of Kohlberg Kravis Roberts & Co. L.P. and its affiliates, you agree to these Terms of Use and Privacy Policy.

Here’s the Deal: Karo Healthcare

Company Karo Healthcare
Industry Healthcare
Woman applying skincare to her face while looking in a mirror.
Play Video

Some of the least talked about healthcare needs can also be some of the most resilient consumer categories. From treating eczema and athlete's foot to managing intimate health and everyday wellness, consumers consistently turn to trusted over-the-counter brands.

Headquartered in Sweden, Karo Healthcare is one of Europe's leading consumer healthcare companies, with a portfolio of well-known brands serving these everyday needs.

KKR agreed to acquire Karo in April 2025, right after “Liberation Day”, a period of significant market volatility. Our in-house capital markets team helped us move quickly and with certainty, enabling us to pursue what we viewed as a compelling opportunity.

We see potential to accelerate Karo’s growth by:

  • Expanding digital and e-pharmacy presence 
  • Re-awakening heritage brands 
  • Driving supply-chain efficiencies 

In this episode of “Here’s the Deal,” learn more about why we invested in Karo and how this deal exemplifies key elements of our investment approach.